Shopping Cart
- Remove All
- Your shopping cart is currently empty
CLZ-8 (Mcl1-IN-8) is an orally active inhibitor of Mcl-1-PUMA (p53 up-regulated mediator of apoptosis) with radioprotective properties.CLZ-8 ameliorates radiation-induced HUVEC cell damage and reduces apoptosis counts, and inhibits radiation-induced overexpression of PUMA.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $43 | In Stock |
Description | CLZ-8 (Mcl1-IN-8) is an orally active inhibitor of Mcl-1-PUMA (p53 up-regulated mediator of apoptosis) with radioprotective properties.CLZ-8 ameliorates radiation-induced HUVEC cell damage and reduces apoptosis counts, and inhibits radiation-induced overexpression of PUMA. |
Targets&IC50 | MCL1:0.3 μM (Ki) |
In vitro | In DLD-1 cells or HUVEC cells, CLZ-8 (0-160 μM; 48 hours for DLD-1 or 24 hours for HUVECs) significantly inhibits PUMA-dependent apoptosis with an IC50 of 38.93 ± 0.91 μM and attenuates radiation-induced apoptosis[1]. |
In vivo | In 6-8 week-old male BALB/c mice, CLZ-8 (100, 200, and 400 mg/kg; intragastric administration, once, 30 minutes prior to irradiation) increases the survival rate of irradiated mice[2]. |
Alias | Mcl1-IN-8, CLZ8, CLZ 8 |
Molecular Weight | 393.5 |
Formula | C22H23N3O2S |
Cas No. | 678158-55-9 |
Smiles | OCCN1CCN(CC1)C1=NC(=O)\C(S1)=C\c1ccc(cc1)-c1ccccc1 |
Relative Density. | 1.27 g/cm3 (Predicted) |
Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 40 mg/mL (101.65 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.